chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pustular
Clinical narrative: Red rash on left breast like a hatch of 2 square inches; Rash is raised; Rash has white little pustules coming out across it; A little fatigue; Slight headache; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised), RASH PUSTULAR (Rash has white little pustules coming out across it), HERPES ZOSTER (Shingles) and FATIGUE (A little fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sore back. Concomitant products included IBUPROFEN for Sore back.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced FATIGUE (A little fatigue) and HEADACHE (Slight headache). In April 2021, the patient experienced HERPES ZOSTER (Shingles). On 19-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised) and RASH PUSTULAR (Rash has white little pustules coming out across it). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. In May 2021, HERPES ZOSTER (Shingles) had resolved. At the time of the report, RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised), RASH PUSTULAR (Rash has white little pustules coming out across it), FATIGUE (A little fatigue) and HEADACHE (Slight headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       This case was linked to MOD-2021-176879 (second dose case) (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received contain significant information added new event shingles and updated outcome of all the reported events from unknown to recovered.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Bad ringing in the ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Bad ringing in the ears) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced TINNITUS (Bad ringing in the ears). At the time of the report, TINNITUS (Bad ringing in the ears) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 30-Apr-2021, The patient's father reported that the patient  experienced ringing of ear a day or two later after the 2nd shot and  was better after 2-3 days, but on 29-Apr-2021 "the ringing of ear" had bothered him again and he wished he didn't receive the vaccine.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: No specific follow-up information recorded.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037821B) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Heart rate increased, Pain, Pyrexia
Clinical narrative: Rapid HR; Extreme body ache; Chills; Extreme fatigue; 103F fever for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid HR), PAIN (Extreme body ache), CHILLS (Chills), FATIGUE (Extreme fatigue) and PYREXIA (103F fever for 2 days) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid HR), PAIN (Extreme body ache), CHILLS (Chills), FATIGUE (Extreme fatigue) and PYREXIA (103F fever for 2 days). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form and IBUPROFEN (MOTRIN IB) at a dose of 1 dosage form. At the time of the report, HEART RATE INCREASED (Rapid HR), PAIN (Extreme body ache), CHILLS (Chills), FATIGUE (Extreme fatigue) and PYREXIA (103F fever for 2 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Ear pain, Ear swelling, Erythema, Feeling hot
Clinical narrative: still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine; feels like her forehead is hot but doesn't have a fever; ear was red and itrritated; ear got sore pain radiated down her neck; pain radiated down her neck; piece outside of her ear swelled up; tiny bit of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (tiny bit of a sore arm), EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck), EAR SWELLING (piece outside of her ear swelled up) and ERYTHEMA (ear was red and itrritated) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (tiny bit of a sore arm). On 19-Mar-2021, the patient experienced EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck) and EAR SWELLING (piece outside of her ear swelled up). On 16-Apr-2021, the patient experienced ERYTHEMA (ear was red and itrritated). On 22-Apr-2021, the patient experienced FEELING HOT (feels like her forehead is hot but doesn't have a fever). On an unknown date, the patient experienced HYPOACUSIS (still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 23-Mar-2021, PAIN IN EXTREMITY (tiny bit of a sore arm), EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck) and EAR SWELLING (piece outside of her ear swelled up) had resolved. At the time of the report, ERYTHEMA (ear was red and itrritated), FEELING HOT (feels like her forehead is hot but doesn't have a fever) and HYPOACUSIS (still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 99 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  On 16 Apr 2021, the patient went to her doctor.Treatment for the events included unspecified ear drops.   This case was linked to MOD-2021-276330, MOD-2021-276330 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received and contained significant information updated new event she cannot hear well as she could prior to the 1st vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, Pain, Pain in extremity
Clinical narrative: still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine; feels like her forehead is hot but doesn't have a fever; ear was red and itrritated; ear got sore pain radiated down her neck; pain radiated down her neck; piece outside of her ear swelled up; tiny bit of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (tiny bit of a sore arm), EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck), EAR SWELLING (piece outside of her ear swelled up) and ERYTHEMA (ear was red and itrritated) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (tiny bit of a sore arm). On 19-Mar-2021, the patient experienced EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck) and EAR SWELLING (piece outside of her ear swelled up). On 16-Apr-2021, the patient experienced ERYTHEMA (ear was red and itrritated). On 22-Apr-2021, the patient experienced FEELING HOT (feels like her forehead is hot but doesn't have a fever). On an unknown date, the patient experienced HYPOACUSIS (still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 23-Mar-2021, PAIN IN EXTREMITY (tiny bit of a sore arm), EAR PAIN (ear got sore pain radiated down her neck), PAIN (pain radiated down her neck) and EAR SWELLING (piece outside of her ear swelled up) had resolved. At the time of the report, ERYTHEMA (ear was red and itrritated), FEELING HOT (feels like her forehead is hot but doesn't have a fever) and HYPOACUSIS (still having issues with her right ear due to hearing/she cannot hear as well as she could prior to the 1st vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 99 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  On 16 Apr 2021, the patient went to her doctor.Treatment for the events included unspecified ear drops.   This case was linked to MOD-2021-276330, MOD-2021-276330 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received and contained significant information updated new event she cannot hear well as she could prior to the 1st vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Headache
Clinical narrative: chest pain off and on; headaches are getting worse; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain off and on) and HEADACHE (headaches are getting worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain off and on) and HEADACHE (headaches are getting worse). At the time of the report, CHEST PAIN (chest pain off and on) and HEADACHE (headaches are getting worse) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not provided.  Concomitant details not provided.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No concomitant medication reported. Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-085474, US-MODERNATX, INC.-MOD-2021-085474 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up was received on 27-MAY-2021. Patient stated that they gave all information over phone and the form was confusing. It contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085474:case for husband US-MODERNATX, INC.-MOD-2021-085474:case for wife
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Dose leaked out of connection between syringe and needle; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Dose leaked out of connection between syringe and needle) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Allergic reaction to drug, Allergic reaction to drug and Blood pressure.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced UNDERDOSE (Dose leaked out of connection between syringe and needle). On 22-Apr-2021, UNDERDOSE (Dose leaked out of connection between syringe and needle) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. No treatment medication information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: been having some headaches off and on that she is not used to having; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (been having some headaches off and on that she is not used to having) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and ROSUVASTATIN for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (been having some headaches off and on that she is not used to having). At the time of the report, HEADACHE (been having some headaches off and on that she is not used to having) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Headache, Myalgia
Clinical narrative: feeling of warmth; headache; myalgia; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feeling of warmth), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included METFORMIN for Diabetes.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FEELING HOT (feeling of warmth), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills). At the time of the report, FEELING HOT (feeling of warmth), HEADACHE (headache), MYALGIA (myalgia) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was receiving blood pressure medication as concomitant medication.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: son is 16 and just got the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose). On 31-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was provided.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: First dose given at 17 years of age; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given at 17 years of age) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given at 17 years of age). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given at 17 years of age) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Headache
Clinical narrative: headache; swelling under eyes after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and EYE SWELLING (swelling under eyes after the vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced HEADACHE (headache) and EYE SWELLING (swelling under eyes after the vaccination). At the time of the report, HEADACHE (headache) and EYE SWELLING (swelling under eyes after the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment details were provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Needle issue, Underdose
Clinical narrative: Half dose Administered; needle of syringe was defective and broken; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken). On 22-Apr-2021, UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered UNDERDOSE (Half dose Administered) and NEEDLE ISSUE (needle of syringe was defective and broken) to be not applicable.    Concomitant and treatment information not provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Just received the 1st dose and stated that she is pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Just received the 1st dose and stated that she is pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 29-Oct-2020 and the estimated date of delivery was 11-Aug-2021. On 22-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Just received the 1st dose and stated that she is pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy.  On 22-Apr-2021, EXPOSURE DURING PREGNANCY (Just received the 1st dose and stated that she is pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was  provided.  No treatment medications were reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching all over; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included Hives (Hives/urticaria). Concurrent medical conditions included Hypertension (Hypertension (Essential)) since January 2017, Drug allergy (Fluticasone caused nasal swelling and sores in nose.), Food allergy (beef, rice (itching)) since 2006, Allergy to molds and Insect bite allergy (dust mites). Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) for Allergy, LISINOPRIL for Hypertension.    On 25-Mar-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRURITUS (Itching all over). On 25-Mar-2021, PRURITUS (Itching all over) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment: allergy medication Symptom text: Patient stated that within 10 minutes of receiving first dose  her nose and scalp began mildly itching which spread to forehead, face and skin throughout the day. Face felt prickly. Itching lasted until the last dose of Xyzal (resolved within 10-15 minutes of Xyzal).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Patient demographics, medical history, concomitant medication, vaccination facility details added. Reporter information, dose details updated.
Age: 53.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain
Clinical narrative: sore throat; cough; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and COUGH (cough) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 001C21A) for COVID-19 vaccination.     No medical history was reported.  The patient's past medical history included No adverse event (no medical history reported). Concomitant products included METHOTREXATE, FOLIC ACID, CALCIUM, MULTIVITAMIN [VITAMINS NOS] and VITAMIN D3 for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 18-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and COUGH (cough). At the time of the report, OROPHARYNGEAL PAIN (sore throat) and COUGH (cough) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, COVID-19: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     This case was linked to MOD-2021-085691.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Rash pruritic
Clinical narrative: Itchy rash left arm; Warm to the touch rash left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash left arm) and FEELING HOT (Warm to the touch rash left arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A/026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced RASH PRURITIC (Itchy rash left arm) and FEELING HOT (Warm to the touch rash left arm). At the time of the report, RASH PRURITIC (Itchy rash left arm) and FEELING HOT (Warm to the touch rash left arm) outcome was unknown. Unknown          No concomitant medications provided.  Treatment included Calamine lotion and cortisone cream   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Non-Significant follow up appended
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Multiple sclerosis, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt pain pain in right hip down his legs like sciatic nerve), MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches), PYREXIA (pyrexia), HEADACHE (headache) and FATIGUE (fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 027b21a04) for COVID-19 vaccination. No medical history was provided by the reporter. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PYREXIA (pyrexia). On 09-Apr-2021, the patient experienced HEADACHE (headache) and FATIGUE (fatigue). On an unknown date, the patient experienced PAIN (felt pain pain in right hip down his legs like sciatic nerve) and MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches). The patient was treated with IBUPROFEN at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (felt pain pain in right hip down his legs like sciatic nerve), MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches), PYREXIA (pyrexia), HEADACHE (headache) and FATIGUE (fatigue) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.5 99.5. On an unknown date, Multiple sclerosis: Inconclusive. On an unknown date, Rheumatoid arthritis: Inconclusive. On an unknown date, X-ray: narrowing in right hip 2mm left hip 4mm. No concomitant medication included. Treatment medications included steroids for inflammation were provided. This case was linked to MOD-2021-085735. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: significant follow up received, patient demographics updated, AE progress/outcome, Lab work, Dose 1 and dose 2 information updated.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rheumatoid arthritis, X-ray
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt pain pain in right hip down his legs like sciatic nerve), MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches), PYREXIA (pyrexia), HEADACHE (headache) and FATIGUE (fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 027b21a04) for COVID-19 vaccination. No medical history was provided by the reporter. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PYREXIA (pyrexia). On 09-Apr-2021, the patient experienced HEADACHE (headache) and FATIGUE (fatigue). On an unknown date, the patient experienced PAIN (felt pain pain in right hip down his legs like sciatic nerve) and MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches). The patient was treated with IBUPROFEN at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (felt pain pain in right hip down his legs like sciatic nerve), MYALGIA (felt pain pain in right hip down his legs like sciatic nerve, bodyaches), PYREXIA (pyrexia), HEADACHE (headache) and FATIGUE (fatigue) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.5 99.5. On an unknown date, Multiple sclerosis: Inconclusive. On an unknown date, Rheumatoid arthritis: Inconclusive. On an unknown date, X-ray: narrowing in right hip 2mm left hip 4mm. No concomitant medication included. Treatment medications included steroids for inflammation were provided. This case was linked to MOD-2021-085735. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: significant follow up received, patient demographics updated, AE progress/outcome, Lab work, Dose 1 and dose 2 information updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Eye allergy, Hypersensitivity
Clinical narrative: allergy on the forehead, on the left side and in both eyes; allergy on the forehead, on the left side and in both eyes; This spontaneous case was reported by a physician and describes the occurrence of EYE ALLERGY (allergy on the forehead, on the left side and in both eyes) and HYPERSENSITIVITY (allergy on the forehead, on the left side and in both eyes) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LOSARTAN POTASSIUM, CLONIDINE HCL, HYDROXYZINE, CARBINOXAMINE MALEATE (OMEGA 100), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN, PENTOXIFYLLINE, CHOLECALCIFEROL, ESCITALOPRAM, CLONAZEPAM, HYDROCHLOROTHIAZIDE (HYDRODIURIL), DICYCLOVERINE HYDROCHLORIDE (BENTYL), PANTOPRAZOLE, CEFIXIME (FLEXERIL [CEFIXIME]) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced EYE ALLERGY (allergy on the forehead, on the left side and in both eyes) and HYPERSENSITIVITY (allergy on the forehead, on the left side and in both eyes). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE ALLERGY (allergy on the forehead, on the left side and in both eyes) and HYPERSENSITIVITY (allergy on the forehead, on the left side and in both eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Vaccination site haemorrhage
Clinical narrative: left arm and leg felt tired; arm bleed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (arm bleed) and MUSCULAR WEAKNESS (left arm and leg felt tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by reporter.     On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (arm bleed). On 20-Apr-2021, the patient experienced MUSCULAR WEAKNESS (left arm and leg felt tired). On 08-Apr-2021, VACCINATION SITE HAEMORRHAGE (arm bleed) outcome was unknown. On 20-Apr-2021, MUSCULAR WEAKNESS (left arm and leg felt tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No information provided about any concomitant and treatment medications.
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Vaccination site pain
Clinical narrative: big rash (rash around the injection site); soreness where she received the vaccination on her right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH and VACCINATION SITE PAIN (soreness where she received the vaccination on her right shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced INJECTION SITE RASH (rash around the injection site) and VACCINATION SITE PAIN (soreness where she received the vaccination on her right shoulder). The patient was treated with Manual therapy of applied alcohol for Injection site rash. On 10-Apr-2021, INJECTION SITE RASH (rash around the injection site) and VACCINATION SITE PAIN (soreness where she received the vaccination on her right shoulder) had resolved. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above included, On 06-Jul-2021: No significant information was received.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Lymphadenopathy, Mouth ulceration
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of mouth ulcers, face swelling (swollen, puffy face), dizziness, pyrexia (intermittent fevers) and chills in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 9, 2021, patient experienced dizziness, pyrexia (intermittent fevers), chills, nausea and fatigue. On Apr 14, 2021, patient experienced face swelling (swollen, puffy face) and lymphadenopathy (swollen lymph nodes). On Apr 18, 2021, patient had a generalized rash. On Apr 21, 2021, patient experienced mouth ulcers. On Apr 22, 2021, patient experienced vomiting. At the time of the report, mouth ulcers, face swelling (swollen, puffy face), dizziness, pyrexia (intermittent fevers), chills, nausea, fatigue, lymphadenopathy (swollen lymph nodes), generalized rash and vomiting outcome: unknown. The reporter did not provide any causality assessments.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Rash, Swelling face, Vomiting
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of mouth ulcers, face swelling (swollen, puffy face), dizziness, pyrexia (intermittent fevers) and chills in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 9, 2021, patient experienced dizziness, pyrexia (intermittent fevers), chills, nausea and fatigue. On Apr 14, 2021, patient experienced face swelling (swollen, puffy face) and lymphadenopathy (swollen lymph nodes). On Apr 18, 2021, patient had a generalized rash. On Apr 21, 2021, patient experienced mouth ulcers. On Apr 22, 2021, patient experienced vomiting. At the time of the report, mouth ulcers, face swelling (swollen, puffy face), dizziness, pyrexia (intermittent fevers), chills, nausea, fatigue, lymphadenopathy (swollen lymph nodes), generalized rash and vomiting outcome: unknown. The reporter did not provide any causality assessments.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain, Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 21, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 22, 2021, patient experienced pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea. At the time of the report, pain (sore), dizziness, rash (started on one side of her stomach and is now on both sides of her stomach) and nausea outcome: unknown. Action taken with mRNA-1273 in response to the event: not applicable. Treatment information not reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Face tingling; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Face tingling) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (Face tingling). At the time of the report, PARAESTHESIA (Face tingling) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment information was provided.  The patient also had other symptom which she could not explain.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Headache, Myalgia, Tenderness
Clinical narrative: splitting headache; sore muscles; ran a temperature of 99.9 F for half a day or better; tenderness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced TENDERNESS (tenderness in the arm). Not Provided    No concomitant details were provided Treatment details include Tylenol  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     (E2B Linked Report).; Sender's Comments:  :2nd dose :wife case for dose 1 :wife case for dose 1
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Headache, Illness, Pyrexia, Underdose
Clinical narrative: Very sick the first day he got the shot; The nurse at the  store in  spilled it on his arm.; The nurse at the  store in  spilled it on his arm.; Fever; Headache; Felt very achy on the left arm; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the store in spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the  store in  spilled it on his arm.), PYREXIA (Fever) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was not provided by reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID], ERGOCALCIFEROL, RETINOL (VITAMIN A + D) and ZINC for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the store in spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the store in spilled it on his arm.), PYREXIA (Fever), HEADACHE (Headache) and VACCINATION SITE PAIN (Felt very achy on the left arm). At the time of the report, ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the  store in  spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the store in spilled it on his arm.), PYREXIA (Fever), HEADACHE (Headache) and VACCINATION SITE PAIN (Felt very achy on the left arm) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 23-May-2021: Outcome of events changed from unknown to recovered, new events such as device connection issue and under-dose were added.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Very sick the first day he got the shot; The nurse at the  store in  spilled it on his arm.; The nurse at the  store in  spilled it on his arm.; Fever; Headache; Felt very achy on the left arm; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the store in spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the  store in  spilled it on his arm.), PYREXIA (Fever) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was not provided by reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID], ERGOCALCIFEROL, RETINOL (VITAMIN A + D) and ZINC for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the store in spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the store in spilled it on his arm.), PYREXIA (Fever), HEADACHE (Headache) and VACCINATION SITE PAIN (Felt very achy on the left arm). At the time of the report, ILLNESS (Very sick the first day he got the shot), UNDERDOSE (The nurse at the  store in  spilled it on his arm.), DEVICE CONNECTION ISSUE (The nurse at the store in spilled it on his arm.), PYREXIA (Fever), HEADACHE (Headache) and VACCINATION SITE PAIN (Felt very achy on the left arm) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 23-May-2021: Outcome of events changed from unknown to recovered, new events such as device connection issue and under-dose were added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Urinary tract infection, Vaccination site erythema
Clinical narrative: I get urinary tract infections, & I feel like I'm getting one; Injection site is little red, where you can tell that a needle went in; A little tired; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (I get urinary tract infections, & I feel like I'm getting one), VACCINATION SITE ERYTHEMA (Injection site is little red, where you can tell that a needle went in) and FATIGUE (A little tired) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     The patient's past medical history included UTI.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced URINARY TRACT INFECTION (I get urinary tract infections, & I feel like I'm getting one), VACCINATION SITE ERYTHEMA (Injection site is little red, where you can tell that a needle went in) and FATIGUE (A little tired). At the time of the report, URINARY TRACT INFECTION (I get urinary tract infections, & I feel like I'm getting one), VACCINATION SITE ERYTHEMA (Injection site is little red, where you can tell that a needle went in) and FATIGUE (A little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.